Yamamoto, Y., Kanai, M., Kou, T., Sugiyama, A., Nakamura, E., Miyake, H., . . . Muto, M. (2019). Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing. J Hum Genet.
استشهاد بنمط شيكاغوYamamoto, Yoshihiro, et al. "Clinical Significance of TP53 Variants As Possible Secondary Findings in Tumor-only Next-generation Sequencing." J Hum Genet 2019.
MLA استشهادYamamoto, Yoshihiro, et al. "Clinical Significance of TP53 Variants As Possible Secondary Findings in Tumor-only Next-generation Sequencing." J Hum Genet 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.